
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2023, titled "Press Release and MDA for Second quarter and Half Year ended 30th September, 2023".
Filed with NSE · · 22 pages · English
Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6Read the transcript of Glenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2023, titled "Press Release and MDA for Second quarter and Half Year ended 30th September, 2023".
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals